Name | Cenerimod |
---|---|
Synonyms |
Y333RS1786
(2S)-3-{4-[5-(2-Cyclopentyl-6-methoxy-4-pyridinyl)-1,2,4-oxadiazol-3-yl]-2-ethyl-6-methylphenoxy}-1,2-propanediol 1,2-Propanediol, 3-[4-[5-(2-cyclopentyl-6-methoxy-4-pyridinyl)-1,2,4-oxadiazol-3-yl]-2-ethyl-6-methylphenoxy]-, (2S)- MFCD30530772 cenerimod |
Description | Cenerimod (ACT-334441) is a potent and orally available sphingosine 1-phosphate 1 receptor (S1P1) agonist extracted from patent WO 2016184939 A1 and WO 2011007324 A1, example 1, with an EC50 of 2.7 nM. |
---|---|
Related Catalog | |
Target |
EC50: 2.7 nM[2] |
References |
[1]. WO 2016184939 A1 [2]. WO 2011007324 A1 |
Density | 1.2±0.1 g/cm3 |
---|---|
Boiling Point | 670.7±65.0 °C at 760 mmHg |
Molecular Formula | C25H31N3O5 |
Molecular Weight | 453.531 |
Flash Point | 359.4±34.3 °C |
Exact Mass | 453.226379 |
LogP | 5.92 |
Vapour Pressure | 0.0±2.2 mmHg at 25°C |
Index of Refraction | 1.578 |
Storage condition | 2-8℃ |